pharmaceutical investing Aquinox and Astellas Announce Exclusive Licensing Agreement for Rosiptor in the Asia-Pacific Region Including Japan
pharmaceutical investing Basilea licenses late-stage oncology drug candidate derazantinib from ArQule
pharmaceutical investing VBL Therapeutics Presents Late Breaking Research Demonstrating Immune-cell Mediated Killing of Cancer Cells by a Novel Bi-specific Antibody at AACR
pharmaceutical investing Moleculin Announces Patients Treated in FDA Approved Phase I/II Annamycin Clinical Trial
pharmaceutical investing Moleculin Enters Agreement with Seidman Cancer Center to Conduct Leukemia Clinical Trials
pharmaceutical investing Moleculin Announces Grant-Funded Collaboration to Expand Understanding of New Discovery
Independent Review of Syntholene Facility Confirms World Class Proof-of-Performance, Supports Potential for Cost-Competitive Synthetic Aviation Fuel
QIMC Extends Natural Hydrogen and Helium Seismic Program Across the Temiscamingue Graben into Ontario with 26.8 km New Seismic Line
Independent Review of Syntholene Facility Confirms World Class Proof-of-Performance, Supports Potential for Cost-Competitive Synthetic Aviation Fuel
Edgewater Wireless Brings Growing Semiconductor Momentum and Dual-Use Innovation to Canada's Semiconductor Symposium 2026
